Specific suppression of allograft rejection by soluble class I antigen and complexes with monoclonal antibody.

PubWeight™: 1.01‹?› | Rank: Top 15%

🔗 View Article (PMID 2219291)

Published in Transplantation on October 01, 1990

Authors

R Sumimoto1, N Kamada

Author Affiliations

1: Department of Experimental Surgery, National Children's Medical Research Centre, Tokyo, Japan.

Articles citing this

Variable chimerism, graft-versus-host disease, and tolerance after different kinds of cell and whole organ transplantation from Lewis to brown Norway rats. Transplantation (1995) 3.63

The fas and fas ligand pathways in liver allograft tolerance. Clin Exp Immunol (1999) 0.89

Interaction of papain-digested HLA class I molecules with human alloreactive cytotoxic T lymphocytes (CTL). Clin Exp Immunol (1993) 0.86

Nuclear antigens and auto/alloantibody responses: friend or foe in transplant immunology. Clin Dev Immunol (2013) 0.82

Expression, by functional proteomics, of spontaneous tolerance in rat orthotopic liver transplantation. Immunology (2004) 0.82

Tolerance Induction in Liver. Int J Organ Transplant Med (2015) 0.81

Lymphocyte cell-cycle inhibition by HLA-G is mediated by phosphatase SHP-2 and acts on the mTOR pathway. PLoS One (2011) 0.81

Soluble HLA: patterns of expression in normal subjects, autoimmune diseases, and transplant recipients. Rheumatol Int (2005) 0.78

Liver graft induced donor specific unresponsiveness without class I and/or class II antigen differences. Transplant Proc (1993) 0.76

Liver transplant tolerance and its application to the clinic: can we exploit the high dose effect? Clin Dev Immunol (2013) 0.76

Peripheral phenotype and gene expression profiles of combined liver-kidney transplant patients. Liver Int (2015) 0.75

Examination of serum class I antigen in liver-transplanted rats. Clin Exp Immunol (1991) 0.75

The role of antibodies in liver graft-induced tolerance in mice: passive transfer of serum and effect of recipient B-cell depletion. Transplant Proc (1995) 0.75

Using a weaning immunosuppression protocol in liver transplantation recipients with hepatocellular carcinoma: a compromise between the risk of recurrence and the risk of rejection? Transl Gastroenterol Hepatol (2017) 0.75

Articles by these authors

(truncated to the top 100)

A role for macrophage scavenger receptors in atherosclerosis and susceptibility to infection. Nature (1997) 5.55

Orthotopic liver transplantation in the rat. Technique using cuff for portal vein anastomosis and biliary drainage. Transplantation (1979) 5.12

Frequent allelic loss of the RB, D13S319 and D13S25 locus in myeloid malignancies with deletion/translocation at 13q14 of chromosome 13, but not in lymphoid malignancies. Leukemia (1999) 5.02

Elevated blood pressure and craniofacial abnormalities in mice deficient in endothelin-1. Nature (1994) 5.00

Cancer incidence in atomic bomb survivors. Part III. Leukemia, lymphoma and multiple myeloma, 1950-1987. Radiat Res (1994) 4.15

Reversal of transplantation immunity by liver grafting. Nature (1981) 3.07

The t(8;21) translocation in acute myeloid leukemia results in production of an AML1-MTG8 fusion transcript. EMBO J (1993) 3.00

Microsatellite instability in acute myelocytic leukaemia developed from A-bomb survivors. Int J Radiat Biol (2001) 2.54

IL23 differentially regulates the Th1/Th17 balance in ulcerative colitis and Crohn's disease. Gut (2008) 2.50

A surgical experience with five hundred thirty liver transplants in the rat. Surgery (1983) 2.48

Establishment of a human acute myeloid leukemia cell line (Kasumi-1) with 8;21 chromosome translocation. Blood (1991) 2.33

Rad51 accumulation at sites of DNA damage and in postreplicative chromatin. J Cell Biol (2000) 2.22

Genes on chromosomes 4, 9, and 19 involved in 11q23 abnormalities in acute leukemia share sequence homology and/or common motifs. Proc Natl Acad Sci U S A (1993) 2.12

S phase specific formation of the human Rad51 protein nuclear foci in lymphocytes. Oncogene (1996) 2.09

A specific chromosome abnormality of t(4;12)(q11-12;p13) in CD7+ acute leukaemia. Br J Haematol (1995) 2.09

Poly(ADP-ribose) polymerase gene disruption conferred mice resistant to streptozotocin-induced diabetes. Proc Natl Acad Sci U S A (1999) 1.85

Fusion of ETV6 to neurotrophin-3 receptor TRKC in acute myeloid leukemia with t(12;15)(p13;q25). Blood (1999) 1.84

Fully allogeneic liver grafting in rats induces a state of systemic nonreactivity to donor transplantation antigens. Transplantation (1980) 1.71

Pancreatic beta-cell-specific targeted disruption of glucokinase gene. Diabetes mellitus due to defective insulin secretion to glucose. J Biol Chem (1995) 1.69

Techniques for orthotopic liver transplantation in the rat and some studies of the immunologic responses to fully allogeneic liver grafts. Transplant Proc (1979) 1.61

Superior outcome of infant acute myeloid leukemia with intensive chemotherapy: results of the Japan Infant Leukemia Study Group. Blood (2001) 1.61

Antitumor cytotoxicity mediated by ligand-activated human V alpha24 NKT cells. Cancer Res (1999) 1.55

A technique for complete thymectomy in adult rats. J Immunol Methods (1994) 1.47

Erythema elevatum diutinum with primary Sjögren syndrome associated with IgA antineutrophil cytoplasmic antibody. Br J Dermatol (2008) 1.47

The immunology of experimental liver transplantation in the rat. Immunology (1985) 1.45

Mutations in the RAD54 recombination gene in primary cancers. Oncogene (1999) 1.45

MLLT3 gene on 9p22 involved in t(9;11) leukemia encodes a serine/proline rich protein homologous to MLLT1 on 19p13. Oncogene (1993) 1.44

Mutations of a novel human RAD54 homologue, RAD54B, in primary cancer. Oncogene (1999) 1.43

Burkitt's lymphoma cell line bearing surface IgA and negative for nuclear antigen of Epstein-Barr virus (EBNA). Jpn J Exp Med (1980) 1.42

Emergence of karyotypically unrelated clone in remission of de novo acute myeloblastic leukaemias. Br J Haematol (1995) 1.39

A retrovirus associated with human adult T-cell leukemia: in vitro activation. Gan (1982) 1.38

Analysis of genetic polymorphism in NQO1, GST-M1, GST-T1, and CYP3A4 in 469 Japanese patients with therapy-related leukemia/ myelodysplastic syndrome and de novo acute myeloid leukemia. Clin Cancer Res (2000) 1.31

The inv(11)(p15q22) chromosome translocation of de novo and therapy-related myeloid malignancies results in fusion of the nucleoporin gene, NUP98, with the putative RNA helicase gene, DDX10. Blood (1997) 1.31

Mechanisms of growth control of Kaposi's sarcoma-associated herpes virus-associated primary effusion lymphoma cells. Blood (1998) 1.28

Establishment and characterization of human signet ring cell gastric carcinoma cell lines with amplification of the c-myc oncogene. Cancer Res (1991) 1.23

High incidence of meningioma among Hiroshima atomic bomb survivors. J Radiat Res (1999) 1.23

Alpha-tocopherol transfer protein is important for the normal development of placental labyrinthine trophoblasts in mice. J Biol Chem (2000) 1.22

Immunosuppressive activity of serum from liver-grafted rats. Passive enhancement of fully allogeneic heart grafts and induction of systemic tolerance. Transplantation (1986) 1.15

Identification of a breakpoint cluster region 3' of the ribophorin I gene at 3q21 associated with the transcriptional activation of the EVI1 gene in acute myelogenous leukemias with inv(3)(q21q26). Blood (1994) 1.14

AML1-MTG8 leukemic protein induces the expression of granulocyte colony-stimulating factor (G-CSF) receptor through the up-regulation of CCAAT/enhancer binding protein epsilon. Blood (2000) 1.13

Antigen-specific immunosuppression induced by liver transplantation in the rat. Transplantation (1984) 1.11

A new ETV6/TEL partner gene, ARG (ABL-related gene or ABL2), identified in an AML-M3 cell line with a t(1;12)(q25;p13) translocation. Blood (2000) 1.10

Increased Evi-1 expression is frequently observed in blastic crisis of chronic myelocytic leukemia. Leukemia (1996) 1.10

Liver transplantation in the rat. Biochemical and histological evidence of complete tolerance induction in non-rejector strains. Transplantation (1983) 1.10

Junctions of the AML1/MTG8(ETO) fusion are constant in t(8;21) acute myeloid leukemia detected by reverse transcription polymerase chain reaction. Blood (1993) 1.09

Effect of cyclosporin A on liver regeneration following partial hepatectomy in the mouse. Transplant Proc (1989) 1.07

Alterations of the double-strand break repair gene MRE11 in cancer. Cancer Res (2001) 1.06

Technical details for safer venous and biliary anastomoses for liver transplantation in the rat. Microsurgery (1998) 1.06

The multiple roles of macrophage scavenger receptors (MSR) in vivo: resistance to atherosclerosis and susceptibility to infection in MSR knockout mice. J Atheroscler Thromb (1997) 1.04

Biochemical activities of lysosomal acid hydrolases in leukemic cells. Clin Chim Acta (1981) 1.04

Geographic heterogeneity of cellular characteristics of acute myeloid leukemia: a comparative study of Australian and Japanese adult cases. Leukemia (2000) 1.02

Fully allogeneic liver grafting and the induction of donor-specific unreactivity. Transplant Proc (1981) 0.99

Detailed modified technique for safer harvesting and preparation of liver graft in the rat. Microsurgery (1996) 0.96

Chromosome aberrations in normal leukocytes induced by the plasma of exposed individuals. Hiroshima J Med Sci (1977) 0.96

Inactivation of multiple tumor-suppressor genes involved in negative regulation of the cell cycle, MTS1/p16INK4A/CDKN2, MTS2/p15INK4B, p53, and Rb genes in primary lymphoid malignancies. Blood (1996) 0.95

Cytogenetic investigation of survivors of the atomic bombings of Hiroshima and Nagasaki. Lancet (1966) 0.94

Application of the piezo-micromanipulator for injection of embryonic stem cells into mouse blastocysts. Contemp Top Lab Anim Sci (2001) 0.92

Breakage and fusion of the TEL (ETV6) gene in immature B lymphocytes induced by apoptogenic signals. Blood (2001) 0.92

Growth inhibition of myeloid leukemia cells by troglitazone, a ligand for peroxisome proliferator activated receptor gamma, and retinoids. Int J Oncol (1999) 0.92

Primary myelofibrosis with myeloid metaplasia and cytogenetically abnormal clones in 2 children with Down's syndrome. Scand J Haematol (1981) 0.92

Serology of liver transplantation in the rat. I. Alloantibody responses and evidence for tolerance in a nonrejector combination. Transplantation (1986) 0.91

Chromosome aberration analysis in persons exposed to low-level radiation from the JCO criticality accident in Tokai-mura. J Radiat Res (2001) 0.90

Neutron energy-dependent initial DNA damage and chromosomal exchange. J Radiat Res (1999) 0.89

Orthotopic rat liver transplantation after long-term preservation by continuous perfusion with fluorocarbon emulsion. Transplantation (1980) 0.89

Germ-line contribution of embryonic stem cells in chimeric mice: influence of karyotype and in vitro differentiation ability. Exp Anim (1997) 0.89

A description of cuff techniques for renal transplantation in the rat. Use in studies of tolerance induction during combined liver grafting. Transplantation (1985) 0.89

Neutron-induced adaptive response studied in go human lymphocytes using the comet assay. J Radiat Res (2001) 0.89

Malignant fibrous histiocytoma. A tumor of facultative histiocytes showing mesenchymal differentiation in cultured cell lines. Cancer (1992) 0.89

Protocol for the technique of orthotopic liver transplantation in the rat. Microsurgery (1993) 0.88

Cellular characteristics of acute myeloblastic leukemia associated with t(8;21)(q22;q22). The Japanese Cooperative Group of Leukemia/Lymphoma. Leuk Lymphoma (1994) 0.88

Interphase fluorescence in situ hybridization overcomes pitfalls of G-banding analysis with special reference to underestimation of chromosomal aberration rates. Cancer Genet Cytogenet (1999) 0.88

Identification of two transcripts of AML1/ETO-fused gene in t(8;21) leukemic cells and expression of wild-type ETO gene in hematopoietic cells. Genes Chromosomes Cancer (1995) 0.87

Clonal deletion as the mechanism of abrogation of immunological memory following liver grafting in rats. Immunology (1985) 0.87

Establishment of an undifferentiated leukemia cell line (Kasumi-3) with t(3;7)(q27;q22) and activation of the EVI1 gene. Jpn J Cancer Res (1996) 0.87

Poly(ADP-ribose) Glycohydrolase deficiency sensitizes mouse ES cells to DNA damaging agents. Curr Cancer Drug Targets (2009) 0.87

Living related liver transplantation. Surg Today (1992) 0.87

Melanoma in association with acquired melanocytic nevus in Japan: a review of cases in the literature. Int J Dermatol (2010) 0.86

Establishment and characteristics of a gastric cancer cell line (HuGC-OOHIRA) producing high levels of G-CSF, GM-CSF, and IL-6: the presence of autocrine growth control by G-CSF. Am J Hematol (1995) 0.86

Multiple possible sites of BRCA2 interacting with DNA repair protein RAD51. Genes Chromosomes Cancer (1998) 0.86

Establishment and characterization of a human gastric scirrhous carcinoma cell line in serum-free chemically defined medium. Int J Cancer (1993) 0.86

Loss of the cyclin-dependent kinase 4-inhibitor (p16; MTS1) gene is frequent in and highly specific to lymphoid tumors in primary human hematopoietic malignancies. Blood (1995) 0.86

The PEBP2beta/CBF beta-SMMHC chimeric protein is localized both in the cell membrane and nuclear subfractions of leukemic cells carrying chromosomal inversion 16. Leukemia (2000) 0.86

Transposition of duplicated chromosomal segment involving fused BCR-ABL gene or ABL oncogene alone in chronic myelocytic leukemia and Ph chromosome-positive acute leukemia with complex karyotypes. Cancer Genet Cytogenet (2000) 0.86

Characterization of a newly established human pancreatic carcinoma cell line, UK Pan-1. Cancer (2000) 0.85

Chronic myelogenous leukemia and Klinefelter's syndrome. Eur J Haematol (1989) 0.85

Establishment and characterization of a novel acute promyelocytic leukemia cell line (UF-1) with retinoic acid-resistant features. Blood (1996) 0.85

Characterization of acute leukemia with t(4;12). Leuk Lymphoma (1997) 0.85

No evidence of increased mutation rates at microsatellite loci in offspring of A-bomb survivors. Radiat Res (2010) 0.85

Analysis and rearrangement of human karyotypes by computer. Cancer Genet Cytogenet (1983) 0.85

24-hour rat liver preservation using UW solution and some simplified variants. Transplantation (1989) 0.85

Evidence for RAD51L1/HMGIC fusion in the pathogenesis of uterine leiomyoma. Genes Chromosomes Cancer (2001) 0.85

Estimation of radiation doses for atomic-bomb survivors in the Hiroshima University Registry. Health Phys (1996) 0.85

[Metastatic malignant lymphoma of the skull with extradural and extracranial extension. Case report]. Neurol Med Chir (Tokyo) (1989) 0.84

A computer program for analysis of chromosome abnormalities. Nihon Ketsueki Gakkai Zasshi (1989) 0.84

[A case of acute myelogenous leukemia (AML) in 10 years course of thrombocytopenia (ITP) with episodes of splenectomy and of delivery (author's transl)]. Rinsho Ketsueki (1978) 0.83

Chromosome aberration analysis in atomic bomb survivors and Thorotrast patients using two- and three-colour chromosome painting of chromosomal subsets. Int J Radiat Biol (1996) 0.83

Migration of donor cells into the thymus is not essential for induction and maintenance of systemic tolerance after liver transplantation in the rat. Immunology (1995) 0.83

Immunological tolerance induced by liver grafting in the rat: splenic macrophages and T cells mediate distinct phases of immunosuppressive activity. Clin Exp Immunol (1991) 0.83

Successful 48-hour preservation of the rat liver by continuous hypothermic perfusion with haemaccel-isotonic citrate solution. Transplantation (1987) 0.83

Chromosome aberrations and culture time. Cytogenetics (1969) 0.83